Pharmafile Logo
Pharmafocus logo
Advanced Search
bhf

British Heart Foundation funding trial of experimental drug designed to prevent blood clots in coronavirus patients

June 16, 2020
Manufacturing and Production COVID-19, blood clots, coronavirus

The British Heart Foundation is funding a trial for a drug that could prevent life-threatening blood clots that have been …

News
nz

New Zealand no longer virus free after two new cases come from Britain

June 16, 2020
Manufacturing and Production COVID-19, New Zealand, coronavirus, pandemic

New Zealand has reported its first new case of coronavirus after two COVID-19 positive women arrived in the country from …

News
sinovac

Sinovac’s COVID-19 vaccine successfully generates immune response at Phase 1/2

June 16, 2020
Manufacturing and Production, Research and Development COVID-19, Sinovac, Vaccine, coronavirus, pharma

As more than 130 efforts to develop an effective vaccine against the novel coronavirus continue to roll on, Beijing-based firm …

News
fda

FDA revokes emergency approval of hydroxychloroquine and chloroquine

June 16, 2020
Manufacturing and Production COVID-19, chloroquine, coronavirus, hydroxychloroquine

The FDA has revoked its emergency approval of hydroxychloroquine and chloroquine due to health risks and a lack of effectiveness …

News
marc_p2

Mundipharma names Marc Princen as Global Chief Executive Officer

June 15, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mundipharma, appointment

Marc Princen was revealed in mid-June as the new Global Chief Executive Officer (CEO) of the Mundipharma network, having taken …

Appointment
covid-19-4922384_640

COVID-19: UK and Europe life sciences regulatory developments

June 15, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Sidley Austin, coronavirus, pharma, regulation

Marie Manley, Partner, and Bethany Wise, Trainee Solicitor, at Sidley Austin look at UK and EU life sciences regulatory developments …

Feature
janssen_latest_logo_on_sign_closer

Tremfya’s skin clearance benefit lasts up to four years in plaque psoriasis patients, Janssen says

June 15, 2020
Research and Development, Sales and Marketing Janssen, Tremfya, plaque psoriasis

Janssen has revealed new data on its interleukin (IL)-23 inhibitor Tremfya (guselkumab) at the American Academy of Dermatology (AAD) virtual …

News
wuhan_citiy

Fear of a coronavirus second wave as China reports highest number of cases in months

June 15, 2020
Sales and Marketing COVID, COVID-19, coronavirus, pandemic

China reported its highest amount of coronavirus cases in months as a new outbreak has been linked to a food …

News
az_vaccinessssssssssss

AstraZeneca to supply Europe with 400 million COVID-19 vaccine doses

June 15, 2020
Sales and Marketing COVID, COVID-19, Vaccine, coronavirus

Multiple European governments have been involved in a deal with AstraZeneca to access a supply of the British drugmakers’ potential …

News

NICE greenlights Roche’s Rozlytrek for ROS1+ advanced non-small cell lung cancer

June 15, 2020
Sales and Marketing NICE, Roche, Rozlytrek, UK, lung cancer

Roche’s Rozlytrek (entrectinib) has secured recommendation for NHS use in England and Wales after NICE backed the drug in final …

News
mr_robot_cancer

AbbVie’s Venclexta plus azacitidine shows improved survival and remissions rates in leukaemia patients

June 15, 2020
Sales and Marketing AbbVie, leukaemia

AbbVie have announced positive results from its latest Phase 3 clinical trial where Venclexta plus azacitidine improved survival and remission …

News
shutterstock_138095450

Takeda jettisons non-core portfolio in Asia Pacific to Celltrion for a potential $278 million

June 12, 2020
Medical Communications, Sales and Marketing Takeda, celltrion, pharma, sale

Takeda continues its mission to reduce its debt in the wake of its $49 billion acquisition of Shire in January …

News
vaccinessssss

Moderna to begin testing its COVID-19 vaccine in 30,000 people starting in July

June 12, 2020
Medical Communications COVID-19, coronavirus

Moderna is to start testing 30,000 people with its coronavirus vaccine beginning in July, after progressing through various trials. The …

News
fda2outsideweb

Mylan and Biocon’s Semglee, biosimilar to Sanofi’s Lantus, approved by FDA for type 1 and 2 diabetes

June 12, 2020
Medical Communications, Sales and Marketing FDA, Lantus, Mylan Biocon, Sanofi, Semglee, diabetes

Mylan and Biocon have scored FDA approval with their insulin glargine injection Semglee, a biosimilar to Sanofi’s Lantus, in both …

News
top_10_image_2_3

Top Ten most popular articles on Pharmafile.com this week

June 12, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing coronavirus, top 10

The news this week continues to be dominated by breakthroughs in COVID-19 treatments, with a US clinical trial of the …

News
nhs_docttttttt

Coronavirus has caused widespread disruption to cancer care in England

June 12, 2020
Medical Communications COVID-19, coronavirus

Figures show that cancer care in England has faced major disruption due to a big drop in referrals from GPs …

News
mdma

Study finds that MDMA has long-term benefits for treating PTSD

June 11, 2020
Business Services MDMA, PTSD

PTSD patients being treated with MDMA experience numerous beneficial effects that hold strong for well after a year after completing …

News
merck-keytruda

MSD’s Keytruda misses the mark at Phase 3 in advanced bladder cancer

June 11, 2020
Research and Development MSD< Keytruda, bladder cancer, pharma, trial failure

MSD has announced the disappointing findings that its anti-PD-1 immunotherapy Keytruda (pembrolizumab), when used either alone or combined with chemotherapy, …

News
eli_lilly

Eli Lilly’s coronavirus antibody treatments could be available by September

June 11, 2020
Business Services COVID, COVID-19, coronavirus

An antibody therapy for coronavirus could be available from Eli Lilly as early as September, according to one of its …

News
shutterstock_273326141

AbbVie and Genmab sign drug development and commercialisation deal worth up to $4bn

June 11, 2020
Research and Development AbbVie, Genmab, partnership, pharma

AbbVie has joined forces with Genmab to develop and commercialise three of the latter’s early-stage Genmab drug products – epcoritamab …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025